MSB 5.24% $1.11 mesoblast limited

This is great news! I begged to differ with an eminent poster...

  1. Yor
    150 Posts.
    lightbulb Created with Sketch. 70
    This is great news! I begged to differ with an eminent poster here, @ecoool2, on the time line but he was right, it takes more time to enroll than I thought, apologies for this.

    We now know for sure that the trial will not be stopped by futility analysis (we had a hunch but still good to know).

    Importantly, the DSMB interim analysis and expected full enrollment will take place in September. I tend to agree with @Tunnah regarding the necessity to complete full enrollment of trial to avoid questioning interim analysis later by adversaries (rather enemies, when one reads the Lassman piece). “Overwhelming” may be considered by some of them as a subjective concept, unless it is categorically overwhelming (100% success). As both interim and full enrollment are corresponding in the same month, it would be preferable to complete the trial and dodge naysayers’ criticism.

    I expect the US market to welcome these results later today very favorably.

    GLASH


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.